Research programme: AZM 131 - Alizyme

Drug Profile

Research programme: AZM 131 - Alizyme

Alternative Names: AZM 131

Latest Information Update: 16 Jul 1999

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Alizyme
  • Developer Alizyme; Institute of Food Research
  • Class
  • Mechanism of Action Lipase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Obesity

Most Recent Events

  • 16 Jul 1999 Discontinued-Clinical for Obesity in United Kingdom (Unknown route)
  • 24 Apr 1998 Investigation in Obesity in United Kingdom (Unknown route)
  • 23 Oct 1997 Yakurigaku Chou Kenkyusho has an option to license AZM 131 products in Japan
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top